Skip to Content
Merck

481181

Silver(I) sulfadiazine

98%

Synonym(s):

Silver sulfadiazine, Sulfadiazine silver

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C10H9AgN4O2S
CAS Number:
Molecular Weight:
357.14
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
244-834-5
MDL number:
Assay:
98%
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

assay

98%

form

powder

InChI key

UEJSSZHHYBHCEL-UHFFFAOYSA-N

InChI

1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1

SMILES string

Nc1ccc(cc1)S(=O)(=O)N([Ag])c2ncccn2

reaction suitability

core: silver

mp

285 °C (dec.) (lit.)

application(s)

PEM fuel cells
material synthesis precursor

Quality Level

Application

Silver(I) sulfadiazine (AgSD) is popularly used for treating second-degree burn wounds as it acts as an antimicrobial agent and prevents infections. Silver sulfadiazine-impregnated polyurethane (PU) foam, chitosan/chondroitin sulfate films may be used for wound dressing.

Storage Class

11 - Combustible Solids

wgk

WGK 2


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Jason Wasiak et al.
The Cochrane database of systematic reviews, 3(3), CD002106-CD002106 (2013-04-02)
An acute burn wound is a complex and evolving injury. Extensive burns produce systemic consequences, in addition to local tissue damage. Treatment of partial thickness burn wounds is directed towards promoting healing and a wide variety of dressings are currently
Ayse Ebru Sakallioglu Abali et al.
Journal of burn care & research : official publication of the American Burn Association, 33(6), e309-e312 (2012-11-13)
As a superstition, homemade decoctions are believed to be beneficial for several diseases. This kind of medical therapy, however, can lead to serious adverse effects. In this report, we present three cases from a single family. Each of the family
Silver sulfadiazine-a new topical therapy for pseudomonas in burns: therapy of pseudomonas infection in burns
Fox CL
Archives of Surgery (Chicago, Ill. : 1960), 96(2), 184-188 (1968)
David J Leaper et al.
International wound journal, 9 Suppl 2, 1-19 (2013-01-05)
The TIME acronym (tissue, infection/inflammation, moisture balance and edge of wound) was first developed more than 10 years ago, by an international group of wound healing experts, to provide a framework for a structured approach to wound bed preparation; a
Meenakshi Venkataraman et al.
AAPS PharmSciTech, 14(1), 254-264 (2013-01-01)
The objective of the present study was to formulate stable silver sulfadiazine (SSD) nanosuspensions and nanogels suitable for topical delivery with a view to increase bactericidal activity in burn therapy. SSD nanosuspensions were formulated using the microprecipitation-high-pressure homogenization technique. An

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service